Rockwell Medical Technologies (NASDAQ: RMTI) reported Q3 EPS of ($0.12), $0.04 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $15.4 million versus the consensus estimate of $16 million.

For earnings history and earnings-related data on Rockwell Medical Technologies (RMTI) click here.